Gibson Energy (8GB) Cotización

You'd have to be the dumbest motha phuckin CEO on the PLANET if you tried to sell Elite right now or ANY time soon.

❌️ Still on the OTC
❌️ All the BE studies failed last year
❌️ Generic OxyContin uncertainty
❌️ Vyvanse JUST launched
❌️ Mikah owns half the A

Looks like Expansion 3 is a Texas DWP project @ 8MTPA. It's written on the new homepage:

Expansion and growth potential of up to 16 MTPA with the Avocet LNG project and a Texas DWP project

https://delfinmidstream.com/

kthomp19 is paid common lunatic hater with LOW IQ LEVEL ,HAVING MENTAL RETARDATION .

$TMSH 1.8B OS trip2 new CEO AI stock Pioneering human centric technologies. 5 entities in AI, mental wellness, performance analytics, sports/entertainment merging into $TMSH.

Acquired Mindwell Solutions Group LLC through new CEO Michael Berman. Here is Michael Berman's bio from Mindw

Nice...

Repeal the Mikah Tax -- To be paid by all shareholders at buyout
1. Cost of Second Tier Suitors
2. Cost of Secret Side Deal with Hakim
3. Cost of Mikah litigation
4. Cost of remaining OTC

All the BE studies failed last year.

Nasrat lied to us when said QUOTE "At least two ANDA's will be filed in 2024".

And he said one of these was the CNS product (Concerta).

I’d like Elite to expand their portfolio. The best way is having ANDA’s approved.

You mean Kirko...

Nasrat was all in years ago and deserves both the credit and the rewards for making this company a force in the generic drug field.

Also Stervc, GCAN CEO Aitan keeps emphasizing in Core Gaming Pr's and the merger video, this:

"Core Gaming has developed cutting edge AI tools using text, language, image and video models to achieve a 50% boost in content production, reducing production time by over 40%, and significa

Well...HELLO mr fung derf...

LET'S WELCOME A NEW MEMBER TO THE ALTRUIST GANG... 🤣

However, my answer is, I don't care about what is posted if its not intended to hurt others

This is good.... So you now know that when Yves says 18-24 months for results... He means 18-24 months !!! Long time off that Belgium ... Very long time in the stock world. Good luck with that

EVERYONE CARES about what happened 10 years ago!

NO ONE CARES about what happened 10 years ago!

Agreed!

Hakim is a miserable failure when it comes to fulfilling his fiduciary duty to Elite shareholders.

Still posting, mr. 6503 posts? While having no financial interest here... 🤣
https://investorshub.advfn.com/boards/profileb.aspx?user=44043

He's been horrible.

Nasrat has been an amazing CEO for investors that have held their shares.

Last month was last month, this is this month and they just voted for another this month.

Sure, I know it is hard to keep track....

LBJ Talks About Shooting Methamphetamine with Jackie Kennedy in Newly Released Presidential Phone Call

https://x.com/RealAlexJones/status/1903544281098330461

In Our Face Stervc!! NVDA and Core Gaming has the same tech and this is why GCAN CEO Aitan Zacharin keep saying his company is going to soon be the Number One "AI Gaming" Company in the world...... AITAN has something up his sleeve.....he knows he has tech that no one else has or has an edge on othe

Now there's a good one, Trin .. !!!

In the current context and considering Missling is from Europe, where approval is sought from EMA. Anavex have run only one tiny adult Rett trial in the U.S., all other trials have been run in countries collaborating with Europe. Considering all this - the Anavex HQ may not be in NYC or anywhere clo

Foreman was a prominent promoter of the jab. Even doing paid commercials

https://x.com/RealAlexJones/status/1903397708368404556

Live Update At 09:18:06 EST: On Friday, March 21, 2025 TransCode Therapeutics Inc. stock [NASDAQ: RNAZ] is trending up by 34.42%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

TransCode Therapeutics received a nod to proc

Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced
Melanoma
80% Progression Free Survival in 25 patients at 6 months
20% (5) patients have shown a complete response following treatment
Disease Control Rate of 84% a